2012 | |
---|---|
Criterium: | Position: |
Overall Score: | > 1000 |
Networking Rank (Reputation): | > 1000 |
Networking Rank (Reputation): | > 1000 |
Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2013 | 0 | 1.467.959 | 8.800 | 1 | ||
2012 | 0 | 5.999.156 | 587.800 | 1 |
Total number of partners: 11
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 11
Frequent / Rare Partner Ratio: 0
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2013-09-01 | Vascular antibody-mediated pharmaceutically induced tumour resection | VAMPIRE | participant | 1.467.959 | 2 |
2012-02-01 | Predictive Genomic Biomarkers Methods for Combination Bevacizumab (Avastin) Therapy in Metastatic Colorectal Cancer | ANGIOPREDICT | participant | 5.999.156 | 11 |